The relationship between DNA methylation and telomere length in dyskeratosis congenita

Aging Cell

Volumn 11, Issue 1, 2012, Pages 24-28

  Gadalla, Shahinaz M ^a   Katki, Hormuzd A ^a   Shebl, Fatma M ^a   Giri, Neelam ^a   Alter, Blanche P ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dyskeratosis congenita; Epigenetic; Human; Methylation; Telomere

Indexed keywords

DNA; DYSKERIN; TCAB1 PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TERC PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA METHYLATION; DYSKERATOSIS CONGENITA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; LYMPHOCYTE; MALE; PRIORITY JOURNAL; TELOMERE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANIMALS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; DYSKERATOSIS CONGENITA; EPIGENESIS, GENETIC; FEMALE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MICE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; RNA; SKIN; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE-BINDING PROTEINS;

EID: 84855825558     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2011.00755.x     Document Type: Article

References (27)

1. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM (2007) Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 110, 1439-1447.
2. Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS (2010) Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br. J. Haematol. 150, 179-188.
3. Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol. Rev. 88, 557-579.
4. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM (2006) Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc. 1, 2365-2376.
5. Benetti R, Garcia-Cao M, Blasco MA (2007) Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39, 243-250.
6. Blasco MA (2007) The epigenetic regulation of mammalian telomeres. Nat. Rev. Genet. 8, 299-309.
7. Canudas S, Houghtaling BR, Bhanot M, Sasa G, Savage SA, Bertuch AA, Smith S (2011) A role for heterochromatin protein 1{gamma} at human telomeres. Genes Dev. 25, 1807-1819.
8. Deng Z, Campbell AE, Lieberman PM (2010) TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle 9, 69-74.
9. Du HY, Mason PJ, Bessler M, Wilson DB (2009a) TINF2 mutations in children with severe aplastic anemia. Pediatr. Blood Cancer 52, 687.
10. Du HY, Pumbo E, Ivanovich J, An P, Maziarz RT, Reiss UM, Chirnomas D, Shimamura A, Vlachos A, Lipton JM, Goyal RK, Goldman F, Wilson DB, Mason PJ, Bessler M (2009b) TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 113, 309-316.
11. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA (2006) DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8, 416-424.
12. Lee ME, Rha SY, Jeung HC, Chung HC, Oh BK (2009) Subtelomeric DNA methylation and telomere length in human cancer cells. Cancer Lett. 281, 82-91.
13. Ng LJ, Cropley JE, Pickett HA, Reddel RR, Suter CM (2009) Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res. 37, 1152-1159.
14. Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42, 301-334.
15. Riethman H (2008) Human telomere structure and biology. Annu. Rev. Genomics Hum. Genet. 9, 1-19.
16. Sasa G, Ribes-Zamora A, Nelson N, Bertuch A (2011) Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood. Clin. Genet. [Epub ahead of print].
17. Savage SA, Alter BP (2009) Dyskeratosis congenita. Hematol. Oncol. Clin. North Am. 23, 215-231.
18. Schoeftner S, Blasco MA (2009) A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J. 28, 2323-2336.
19. Tost J, Gut IG (2007) DNA methylation analysis by pyrosequencing. Nat. Protoc. 2, 2265-2275.
20. Vera E, Canela A, Fraga MF, Esteller M, Blasco MA (2008) Epigenetic regulation of telomeres in human cancer. Oncogene 27, 6817-6833.
21. Vulliamy TJ, Knight SW, Mason PJ, Dokal I (2001) Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27, 353-357.
22. Vulliamy T, Beswick R, Kirwan M, Hossain U, Walne A, Dokal I (2010) Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2. Clin. Genet. [Epub ahead of print].
23. Walne AJ, Dokal I (2009) Advances in the understanding of dyskeratosis congenita. Br. J. Haematol. 145, 164-172.
24. Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I (2008) TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 112, 3594-3600.
25. Yehezkel S, Segev Y, Viegas-Pequignot E, Skorecki K, Selig S (2008) Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum. Mol. Genet. 17, 2776-2789.
26. Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121-130.
27. Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE (2011) Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 25, 11-16.